Dr David Sullivan is a physician / chemical pathologist in the Department of Chemical Pathology at Royal Prince Alfred Hospital and an Associate Professor, Faculty of Medicine at the University of Sydney Central Clinical School.
David has a long-term interest in lipid metabolism with particular emphasis on the environmental component (especially dietary) of gene – environment interactions contributing to cardiovascular disease. He has been involved in the early use of many forms of lipid-lowering intervention. He supports the improvement of detection and management of severe inherited dyslipidaemia, such as that seen in Familial Hypercholesterolaemia.
David has experience in several international clinical posts, including World Health Organization (WHO) Fellowship at the MRC Lipoprotein Unit, Royal Postgraduate School of Medicine, Hammersmith Hospital, London. He co-ordinated international clinical studies from the WHO reference lipid laboratory in Wageningen, Netherlands where he worked with the originator of the technique known as Mendelian Randomisation. In addition to his clinical and teaching activities, he has served on numerous clinical committees including the management committees of the LIPID and FIELD trials.
Current research interests include biomarkers and post-prandial metabolism.